%0 Journal Article
%T Analytical Method Development and Validation of Some Biosimilar Drugs by High Performance Thin Layer Chromatography
%A Husna Kanwal Qureshi
%A Ciddi Veeresham
%J American Journal of Analytical Chemistry
%P 121-133
%@ 2156-8278
%D 2023
%I Scientific Research Publishing
%R 10.4236/ajac.2023.143007
%X A simple and rapid HPTLC analytical method has been developed and validated for the determination of Etanercept and Filgrastim in pure form and in marketed formulation. Both the drugs were chromatographed on silica gel 60 F254s HPTLC plates, as stationary phase. The mobile phase optimized for Filgrastim and Etanercept was Water: n-butanol (7.5:2.5 v/v) and Isopropyl alcohol: water (6.5:4.5 v/v), respectively. The chromatogram obtained was scanned at 225 nm and 222 nm for filgrastim and etanercept which resulted in a retention factor of 0.45 ¡À 0.07 and 0.32 ¡À 0.03, respectively. The method was validated for parameters like linearity, accuracy, precision, specificity and robustness. Recovery studies were performed at three concentration levels, to demonstrate suitability, accuracy and precision of proposed method. Statistical analysis proved that the proposed method is accurate and reproducible with linearity in the range of 500 to 3000 ng/band for filgrastim and 200 to 1200 ng/band for etanercept. The limit of detection and limit of quantification for filgrastim was found to be 63.418 ng/band and 192.177 ng/band. For etanercept, LOD and LOQ were found to be 33.381 ng/band and 101.153 ng/band, respectively. The proposed method can be employed for the routine analysis of selected biosimilars.
%K Biosimilars
%K Etanercept
%K Filgrastim
%K Method Development
%K Validation
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=123519